Search by Drug Name or NDC

    NDC 68382-0582-10 Liothyronine sodium 5 ug/1 Details

    Liothyronine sodium 5 ug/1

    Liothyronine sodium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is LIOTHYRONINE SODIUM.

    Product Information

    NDC 68382-0582
    Product ID 68382-582_15ed7dff-a305-4a76-aedd-f932fa27b36c
    Associated GPIs 28100020100305
    GCN Sequence Number 006659
    GCN Sequence Number Description liothyronine sodium TABLET 5 MCG ORAL
    HIC3 P3A
    HIC3 Description THYROID HORMONES
    GCN 26341
    HICL Sequence Number 002850
    HICL Sequence Number Description LIOTHYRONINE SODIUM
    Brand/Generic Generic
    Proprietary Name Liothyronine sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Liothyronine sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units ug/1
    Substance Name LIOTHYRONINE SODIUM
    Labeler Name Zydus Pharmaceuticals (USA) Inc.
    Pharmaceutical Class Triiodothyronine [CS], l-Triiodothyronine [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA214803
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0582-10 (68382058210)

    NDC Package Code 68382-582-10
    Billing NDC 68382058210
    Package 1000 TABLET in 1 BOTTLE (68382-582-10)
    Marketing Start Date 2021-02-01
    NDC Exclude Flag N
    Pricing Information N/A